Serum IFN-γ is increased in patients with active vitiligo

doi:10.16352/j.issn.1001-6325.2022.07.1067

Basic & Clinical Medicine ›› 2022, Vol. 42 ›› Issue (7): 1067-1070.doi: 10.16352/j.issn.1001-6325.2022.07.1067

• Original Articles • Previous Articles Next Articles

Serum IFN-γ is increased in patients with active vitiligo

ZHAO Xiao-ling¹, HE Run-zhi², SUN Yu-jiao³, ZHANG Xiao-chong⁴, YANG Lin-fang³, WANG Rui³, CHENG Fang^3*

1. Cancer Laboratory; 2. Department 3 of Neurosurgery; 3. Department of Dermatology; 4. Department of Scientific Research and Teaching, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai 054001, China

Received:2021-01-04 Revised:2021-10-15 Online:2022-07-05 Published:2022-06-29
Contact: * 1299233987@qq.com

Abstract

Abstract: Objective To examine serum C-reactive protein (CRP), tumor necrosis factor-α(TNF-α), tumor necrosis factor-β(TNF-β), E-cadherin (E-cad), human interferon-γ (IFN-γ) and cluster of differentiation 8 (CD8) in patients with vitiligo. Methods From May 2017 to December 2018, 60 patients with vitiligo (30 cases in active phase group and 30 cases in stable stage group) and 30 cases as control group collected from physical examination center joined the research program. The content of serum CRP, TNF-α, TNF-β, E-cad, IFN-γ and CD8 were compared among the three groups by enzyme-linked immunosorbent assay (ELISA). Results The content of serum CRP, TNF-α, TNF-β and IFN-γ in patients with active and stable vitiligo were significantly higher(P＜0.05). The content of serum IFN-γ in patients with active vitiligo was significantly higher than that in patients with stable vitiligo(P＜0.05)and significantly decreased after 6 months of treatment(P＜0.05). Conclusions The content of serum IFN-γ might be used as a biomarker in laboratory to evaluate the activity of vitiligo.

Key words: vitiligo, cytokines, active stage, pathogenesis

CLC Number:

R446.11

ZHAO Xiao-ling, HE Run-zhi, SUN Yu-jiao, ZHANG Xiao-chong, YANG Lin-fang, WANG Rui, CHENG Fang. Serum IFN-γ is increased in patients with active vitiligo[J]. Basic & Clinical Medicine, 2022, 42(7): 1067-1070.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.07.1067

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I7/1067

References 13

[1]	Ezzedine K, Eleftheriadou V, Whitton M, et al. Vitiligo[J]. Lancet, 2015,386:74-84.
[2]	Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults[J]. Int J Dermatol, 2012,51:1206-1212.
[3]	Halder RM, Chappell JL. Vitiligo update[J]. Semin Cutan Med Surg, 2009,28:86-92.
[4]	Chen D, Tuan H, Zhou EY, et al. Quality of life of adult vitiligo patients using camouflage: a survey in a Chinese vitiligo community[J]. PLoS One, 2019,14:e0210581. doi: 10.1371/journal.pone.0210581
[5]	杨红, 王克玉, 王奕. 过氧化氢对白癜风患者黑素细胞的氧化损伤[J]. 基础医学与临床, 2006,26: 1363-1366.
[6]	许爱娥. 白癜风病期评估及干预[J]. 中华皮肤科杂志, 2017,50:765-767.
[7]	Wang D, Su L, Huang D, et al. Downregulation of E-cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR[J]. Mol Cancer, 2011,10:116. doi: 10.1186/1476-4598-10-116
[8]	Levy C, Khaled M. Ecad vitiliGONE[J]. Pigment Cell Melanoma Res, 2015,28:376-377.
[9]	于建秀, 钱雷, 徐昌辉, 等. 2型糖尿病患者外周血CD8~+CD25~+Foxp3~+Treg细胞检测及意义[J]. 基础医学与临床, 2019,39:989-994.
[10]	Abdallah M, Lotfi R, Othman W, et al. Assessment of tissue FoxP3+, CD4+ and CD8+ T-cells in active and stable nonsegmental vitiligo[J]. Int J Dermatol, 2014,53:940-946.
[11]	Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-gamma: an overview of signals, mechanisms and functions[J]. J Leukoc Biol, 2004,75:163-189.
[12]	Dillinger B, Ahmadi-Erber S, Lau M, et al. IFN-γ and tumor gangliosides: implications for the tumor microenvironment[J]. Cell Immunol, 2018,325:33-40.
[13]	黄新绿, 杜娟, 王芳, 等. 白癜风细胞免疫学发病机制及靶向免疫治疗新进展[J]. 中国皮肤性病学杂志, 2020,34:1197-1200.

[1]	LIN Bai-bai, QIAN Feng-hua, QIAN Yi-ming, ZHAO Lei, SUN Qi, CHU Meng-yao, SHEN Meng-wen. Research progress of sepsis complicated with capillary leakage syndrome [J]. Basic & Clinical Medicine, 2022, 42(7): 1144-1147.
[2]	LI Xiao-guang, YANG Lu, LIU Xu-dong, JIA Xin-miao, CHENG Yan-fei, CUI Li-ying. Research progress of inflammatory cytokines in the diagnosis and treatment of amyotrophic lateral sclerosis [J]. Basic & Clinical Medicine, 2022, 42(6): 964-968.
[3]	SHU Meng-xuan, YUAN Fang-chen, ZHOU Meng-qi, TU Shi-yan, XU Yue, QIN Hong-yan. Research progress in colitis-induced hepatic barrier dysfunction [J]. Basic & Clinical Medicine, 2022, 42(1): 149-153.
[4]	ZOU Xue-lian, HU Wen, LEI Zi-xian, WANG Hong-juan, XU Chen, Halina HAIRUOLA, KANG Xiao-jing. Kaempferol alleviates oxidative stress injury of human keratinocytes [J]. Basic & Clinical Medicine, 2021, 41(8): 1103-1108.
[5]	WANG Hang-hang, WANG Dao-xin. Research advances in NETs and acute respiratory distress syndrome [J]. Basic & Clinical Medicine, 2021, 41(7): 1047-1051.
[6]	CHEN Yun-kun, LIU Huang, ZHANG Wen-bin, WANG Jie. Analysis of Traditional Chinese Medicine syndrome types in 52 COVID-19 patients with positive nucleic acid retest after discharge [J]. Basic & Clinical Medicine, 2021, 41(4): 558-561.
[7]	LAN Fei, LIU Tai-yang, YANG Jie. Advances in the role of intestinal ion channels in the pathogenesis of irritable bowel syndrome [J]. Basic & Clinical Medicine, 2020, 40(8): 1135-1139.
[8]	LIANG Wen-lin, LI Jun, JIN Guang-ming, YAN Jin-sheng, YAO Yuan. Effect of astragaloside on renal function and serum IL-1β and IL-17 in mice with mesangial proliferative glomerulonephritis [J]. Basic & Clinical Medicine, 2020, 40(12): 1666-1670.
[9]	. Research progress of regulatory B cells promoting the development of tumor [J]. Basic & Clinical Medicine, 2019, 39(1): 110-114.
[10]	. Dexmedetomidine mitigate lung ischemia-reperfusion injury in mice by inhibition of TLR4 activation [J]. Basic & Clinical Medicine, 2018, 38(7): 967-972.
[11]	Wei LUO Gu Haiying. An overview of mechanism research on Helicobacter pylori pathogenic factors [J]. Basic & Clinical Medicine, 2018, 38(5): 713-716.
[12]	. Progress in the mechanism study on colitis associated cancer [J]. Basic & Clinical Medicine, 2018, 38(4): 568-572.
[13]	. Anaplastic lymphoma kinase and neuroblastoma [J]. Basic & Clinical Medicine, 2018, 38(12): 1791-1794.
[14]	. Periostin siRNA transfection inhibits ox-LDL-induced human aortic endothelial cell line injury [J]. Basic & Clinical Medicine, 2017, 37(7): 1026-1030.
[15]	. Progress in the research of acquired heterotopic ossification [J]. Basic & Clinical Medicine, 2017, 37(11): 1634-1639.

Serum IFN-γ is increased in patients with active vitiligo

PDF

Knowledge

Abstract

Cite this article

share this article

References 13

Related Articles 15

Recommended Articles

Metrics

Comments